PACI, SABRINA
PACI, SABRINA
DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA (attivo dal 01/01/1999 al 26/04/2012)
A case of glycogenosis type IB associated with MGUS
2011-08-01 E. Riva, M. Gasparri, I. Giulini Neri, S. Paci
Absence of severe recurrent infections in GSD IB
2008-09-01 S. Paci, M. Gasparri, I. Giulini Neri, G. Cagnoli, E. Salvatici, M. Giovannini
Acidi grassi polinsaturi a lunga catena (LCPUFA)
2007-09-01 S. Paci
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy
2007-08-01 M. Giovannini, D. Casero, S. Paci, M. Gasparri, S. El Oksha, M. Bonza, A.M. Lammardo, E. Salvatici, C. Agostoni
Assetto lipidico nei pazienti con glicogenosi: l'esperienza della Clinica Pediatrica dell'Ospedale San Paolo
2006-11-23 S. Paci, I. Giulini Neri, M. Gasparri, M. Torcoletti, M. Giovannini
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia
2009-10-01 M. Giovannini, M. Bonza, S. Paci, D. Bertolotti, G. Cagnoli, E. Salvatici, E. Riva
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I)
2011-08-01 E. Riva, S. Pieretti, S. Paci, I. Giulini Neri, E. Salvatici, M. Giovannini
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA)
2011-08-01 E. Riva, E. Salvatici, V. Scelsa, G. Cagnoli, S. Vincenti, S. Paci, M. Giovannini
Bone mineralization in GSD I and III
2008-09-01 E. Riva, S. Paci, I. Giulini Neri, M. Gasparri, G. Cagnoli, M. Bonza, C. Agostoni
Bone mineralization in type 1 glycogen storage disease: a two years follow up study
2010-09-01 E. Riva, I. Giulini Neri, M. Gasparri, J. Scotti Gerber, E. Salvatici, D. Minghetti, G. Cagnoli, S. Paci
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why
2012-09-01 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why
2012-09-01 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation
2013-01-01 E. Salvatici, C. Pederiva, M.E. Capra, S. Vincenti, S. Paci, M. Giovannini
Case report: GSD type 1. and pregnancy
2008-09-01 S. Paci, M. Gasparri, I. Giulini Neri, M. Bonza, E. Salvatici, M. Giovannini
Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: Clinical and molecular report
2017-01-01 D. Allegrini, S. Penco, A. Pece, A. Autelitano, G. Montesano, S. Paci, C. Montanari, A. Maver, B. Peterlin, G. Damante, L.M. Rossetti
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report
2012-09-01 S. Paci, S. Vincenti, R. Selmi, E. Salvatici, E. Riva
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica
2011-10-01 E. Riva, E. Salvatici, S. Paci, V. Scelsa, S. Vincenti, M. Giovannini
Determinants of Plasma Docosahexaenoic Acid Levels and Their Relationship to Neurological and Cognitive Functions in PKU Patients: A Double Blind Randomized Supplementation Study
2018-12-01 H. Demmelmair, A. Macdonald, U. Kotzaeridou, P. Burgard, D. Gonzalez-Lamuno, E. Verduci, M. Ersoy, G. Gokcay, B. Alyanak, E. Reischl, W. Müller-Felber, F. Faber, U. Handel, S. Paci, B. Koletzko
Diagnosi differenziale delle linfoadenopatie
2008-03-01 S. Paci, M. Gasparri, M.E. Capra, S. El Oksha, S. Bellini
Diagnosticare la malattia di Fabry per curarla
2008-11-01 E. Salvatici, M. Bonza, S. Bellini, S. Paci, E. Riva